High Tower Advisors, LLC Singular Genomics Systems, Inc. Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$0.4 - $0.61 $44,000 - $67,101	110,002 Added 26.3%	528,324 $269,000
Q4 2023 Feb 12, 2024	BUY	$0.33 - $0.58 $49,500 - $87,000	150,000 Added 55.9%	418,322 $192,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $23,400 - $38,400	30,000 Added 12.59%	268,322 $222,000
Q1 2023 May 11, 2023	BUY	$1.1 - $2.95 $43,890 - $117,705	39,900 Added 20.11%	238,322 $288,000
Q4 2022 Feb 08, 2023	SELL	$1.82 - $2.71 $18,382 - $27,371	-10,100 Reduced 4.84%	198,422 $398,000
Q3 2022 Nov 09, 2022	BUY	$2.5 - $4.73 $125,000 - $236,500	50,000 Added 31.54%	208,522 $521,000
Q1 2022 May 12, 2022	BUY	$5.94 - $12.09 $59,994 - $122,109	10,100 Added 6.8%	158,522 $1 Million
Q4 2021 Feb 10, 2022	BUY	$10.45 - $16.9 $1.55 Million - $2.51 Million	148,422 New	148,422 $1.72 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.56B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.